Search

Jianping P Chao

age ~57

from North Wales, PA

Also known as:
  • Jianping Chao
  • Jianming Ming Cao
  • Jianping Yan
  • Jianming Cao
  • Chao Jianping

Jianping Chao Phones & Addresses

  • North Wales, PA
  • Hopkinton, MA
  • Westborough, MA
  • New Providence, NJ
  • Scotch Plains, NJ
  • Summit, NJ
  • Lower Gwynedd, PA
  • Rochester, NY
  • Clark, NJ
  • Ann Arbor, MI

Us Patents

  • Farnesyl Protein Transferase Inhibitors

    view source
  • US Patent:
    6372747, Apr 16, 2002
  • Filed:
    Dec 16, 1999
  • Appl. No.:
    09/465553
  • Inventors:
    Arthur G. Taveras - Denville NJ
    Ronald J. Doll - Maplewood NJ
    Alan B. Cooper - West Caldwell NJ
    Johan A. Ferreira - Bensalem PA
    Timothy Guzi - Chatham NJ
    Dinanath F. Rane - Morganville NJ
    Viyyoor M. Girijavallabhan - Parsippany NJ
    Cynthia J. Aki - Rutherford NJ
    Jianping Chao - Summit NJ
    Carmen Alvarez - Roselle Park NJ
    Joseph M. Kelly - Parlin NJ
    Tarik Lalwani - Philadelphia PA
    Jagdish A. Desai - Spotswood NJ
    James J-S Wang - Westfield NJ
  • Assignee:
    Schering Corporation - Kenilworth NJ
  • International Classification:
    A61K 31496
  • US Classification:
    51425303, 51425405, 51425501, 514252, 514290, 514326, 544361, 544370, 546 93, 546210
  • Abstract:
    Disclosed are compounds of the formula: wherein R represents an imidazole ring; R represents a carbamate, urea, amide or sulfonamide group; R represents H when the alkyl chain between the amide group and the R imidazole group is substituted, or R represents a substituent such as arylalkyl, heteroarylalkyl or cycloalkyl; and the remaining substituents are as defined herein. Also disclosed are compounds wherein R is H, and the alkyl chain between the amide group and the R imidazole group is unsubstituted. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.
  • Inhibitors Of Farnesyl-Protein Transferase

    view source
  • US Patent:
    6432959, Aug 13, 2002
  • Filed:
    Dec 22, 1999
  • Appl. No.:
    09/469465
  • Inventors:
    Alan B. Cooper - West Caldwell NJ
    Ronald J. Doll - Maplewood NJ
    Johan A. Ferreira - Bensalem PA
    Ashit Ganguly - Upper Montclair NJ
    Viyyoor M. Girijavallabhan - Parsippany NJ
    Arthur G. Taveras - Denville NJ
    Jianping Chao - Summit NJ
    John J. Baldwin - Gwynedd Valley PA
    Chia-Yu Huang - Plainsboro NJ
    Ge Li - Lawrenceville NJ
  • Assignee:
    Schering Corporation - Kenilworth NJ
  • International Classification:
    A61K 31496
  • US Classification:
    51425309, 51425402, 51425405, 544364, 544367, 544370
  • Abstract:
    Novel compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel aminooxyamide compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammals such as a human.
  • Farnesyl Protein Transferase Inhibitors

    view source
  • US Patent:
    6740661, May 25, 2004
  • Filed:
    Dec 20, 2001
  • Appl. No.:
    10/026999
  • Inventors:
    Arthur G. Taveras - Denville NJ
    Ronald J. Doll - Maplewood NJ
    Alan B. Cooper - West Caldwell NJ
    Johan A. Ferreira - Bensalem PA
    Timothy Guzi - Chatham NJ
    Alan K. Mallams - Hackettstown NJ
    Dinanath F. Rane - Morganville NJ
    Viyyoor M. Girijavallabhan - Parsippany NJ
    Adriano Afonso - West Caldwell NJ
    Cynthia J. Aki - Rutherford NJ
    Jianping Chao - Summit NJ
    Carmen Alvarez - Roselle Park NJ
    Joseph M. Kelly - Parlin NJ
    Tarik Lalwani - Philadelphia PA
    Jagdish A. Desai - Spotswood NJ
    James J-S Wang - Westfield NJ
    Jay Weinstein - Upper Montclair NJ
  • Assignee:
    Schering Corporation - Kenilworth NJ
  • International Classification:
    A61K 314545
  • US Classification:
    514290, 514326, 51425501, 51425211, 51425303, 51425405, 514256, 546 93, 546210, 544361, 544370, 544333, 544357
  • Abstract:
    Disclosed are compounds of the formula: wherein R represents an imidazole ring; R represents a carbamate, urea, amide or sulfonamide group; R represents H when the alkyl chain between the amide group and the R imidazole group is substituted, or R represents a substituent such as arylalkyl, heteroarylalkyl or cycloalkyl; and the remaining substituents are as defined herein. Also disclosed are compounds wherein R is H, and the alkyl chain between the amide group and the R imidazole group is unsubstituted. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.
  • Farnesyl Protein Transferase Inhibitors

    view source
  • US Patent:
    6800636, Oct 5, 2004
  • Filed:
    Dec 20, 2001
  • Appl. No.:
    10/028251
  • Inventors:
    Timothy Guzi - Chatham NJ
    Dinanath F. Rane - Morganville NJ
    Alan K. Mallams - Hackettstown NJ
    Alan B. Cooper - West Caldwell NJ
    Ronald J. Doll - Maplewood NJ
    Viyyoor M. Girijavallabhan - Parsippany NJ
    Arthur G. Taveras - Denville NJ
    Corey Strickland - North Plainfield NJ
    Joseph M. Kelly - Parlin NJ
    Jianping Chao - Summit NJ
  • Assignee:
    Schering Corporation - Kenilworth NJ
  • International Classification:
    A61K 314545
  • US Classification:
    514290, 514325, 51425302, 51421705, 5142282, 5142328, 514218, 546 93, 546195, 546203, 540544, 540598, 540575, 544 60, 544121, 544361, 544370, 544360
  • Abstract:
    Disclosed are compounds of the formula: wherein R represents a cyclic moiety to which is bound an imodazolylalkyl group; R represents a carbamate, urea, amide or sulfonamide group; and the remaining substituents are as defined herein. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.
  • 3,4-Di-Substituted Pyridazinediones As Cxc Chemokine Receptor Antagonists

    view source
  • US Patent:
    6878709, Apr 12, 2005
  • Filed:
    Jan 2, 2003
  • Appl. No.:
    10/335789
  • Inventors:
    Arthur G. Taveras - Denville NJ, US
    Michael Dwyer - Scotch Plains NJ, US
    Jianping Chao - Summit NJ, US
    John J. Baldwin - Gwynedd Valley PA, US
    J. Robert Merritt - Ewing NJ, US
    Ge Li - Shanghai, CN
    Jianhua Chao - Pompton Lakes NJ, US
    Younong Yu - Piscataway NJ, US
  • Assignee:
    Schering Corporation - Kenilworth NJ
    Pharmacopeia Drug Discovery, Inc. - Princeton NJ
  • International Classification:
    A61K031/50
    A61K031/501
    C07D237/22
    C07D405/12
    C07D409/12
  • US Classification:
    514247, 51425201, 51425205, 544238, 544240
  • Abstract:
    Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
  • 3,4-Di-Substituted Maleimide Compounds As Cxc Chemokine Receptor Antagonists

    view source
  • US Patent:
    6903131, Jun 7, 2005
  • Filed:
    Oct 11, 2002
  • Appl. No.:
    10/269775
  • Inventors:
    Arthur G. Taveras - Denville NJ, US
    Michael Dwyer - Scotch Plains NJ, US
    Johan A. Ferreira - Bethlehem PA, US
    Viyyoor M. Girijavallabhan - Parsippany NJ, US
    Jianping Chao - Summit NJ, US
    John J. Baldwin - Gwynedd Valley PA, US
    J. Robert Merritt - Ewing NJ, US
    Ge Li - Shanghai, CN
  • Assignee:
    Schering Corporation - Kenilworth NJ
    Pharmacopeia Drug Discovery, Inc. - Cranbury NJ
  • International Classification:
    A61K031/4015
    C07D409/12
  • US Classification:
    514425, 548517, 548527, 548406, 548204, 514422
  • Abstract:
    Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
  • 3,4-Di-Substituted Cyclobutene-1,2-Diones As Cxc-Chemokine Receptor Ligands

    view source
  • US Patent:
    7132445, Nov 7, 2006
  • Filed:
    Jul 30, 2003
  • Appl. No.:
    10/630258
  • Inventors:
    Arthur G. Taveras - Denville NJ, US
    Cynthia J. Aki - Livingston NJ, US
    Richard W. Bond - Union NJ, US
    Jianping Chao - Summit NJ, US
    Michael Dwyer - Scotch Plains NJ, US
    Johan A. Ferreira - Bethlehem PA, US
    Jianhua Chao - Pompton Lakes NJ, US
    Younong Yu - Scotch Plains NJ, US
    John J. Baldwin - Gwynedd Valley PA, US
    Bernd Kaiser - Wallingford CT, US
    Ge Li - Shanghai, CN
    J. Robert Merritt - Ewing NJ, US
    Purakkattle J. Biju - Scotch Plains NJ, US
    Laura L. Rokosz - Union NJ, US
    James P. Jakway - Bridgewater NJ, US
    Gaifa Lai - Edison NJ, US
    Minglang Wu - Monmouth Junction NJ, US
    Evan A. Hecker - Austin TX, US
    Daniel Lundell - Flemington NJ, US
    Jay S. Fine - Bloomfield NJ, US
  • Assignee:
    Schering Corporation - Kenilworth NJ
    Pharmacopeia Drug Discovery, Inc. - Cranbury NJ
  • International Classification:
    A61K 31/341
    A61K 31/343
    A61K 31/381
    C07D 333/10
    C07D 33/72
  • US Classification:
    514438, 514443, 514469, 514471, 549 58, 549 77, 549469, 549494
  • Abstract:
    There are disclosed compounds of the formula.
  • 3,4-Di-Substituted Cyclobutene-1,2-Diones As Cxc-Chemokine Receptor Ligands

    view source
  • US Patent:
    7947720, May 24, 2011
  • Filed:
    Jan 13, 2009
  • Appl. No.:
    12/352781
  • Inventors:
    Arthur G. Taveras - Southborough MA, US
    Cynthia J. Aki - Livingston NJ, US
    Richard W. Bond - Union NJ, US
    Jianping Chao - Summit NJ, US
    Michael Dwyer - Scotch Plains NJ, US
    Johan A. Ferreira - Bensalem PA, US
    Jianhua Chao - Pompton Lakes NJ, US
    Younong Yu - East Brunswick NJ, US
    John J. Baldwin - Gwynedd Valley PA, US
    Bernd Kaiser - Plainsboro NJ, US
    Ge Li - Shanghai, CN
    J. Robert Merritt - Ewing NJ, US
    Purakkattle J. Biju - Piscataway NJ, US
    Laura L. Rokosz - Union NJ, US
  • Assignee:
    Schering Corporation - Kenilworth NJ
    Pharmacopeia Drug Discovery - Cranbury NJ
  • International Classification:
    C07D 261/04
    C07D 327/04
    A01N 43/80
    A01N 43/06
  • US Classification:
    514378, 514444, 548246, 549 7
  • Abstract:
    There are disclosed compounds of the formula.

Lawyers & Attorneys

Jianping Chao Photo 1

Jianping Chao - Lawyer

view source
Licenses:
New Jersey - Active 2003
Jianping Chao Photo 2

Jianping Chao, Summit NJ - Lawyer

view source
Address:
Chao & Associates
Po Box 423, Summit, NJ 07902
(908)5220503 (Office)
Licenses:
New York - Currently registered 2004
Education:
Rutgers

Get Report for Jianping P Chao from North Wales, PA, age ~57
Control profile